Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol

Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol

Introduction: In previous studies, we successfully designed complex multicompartmental microcapsules as a platform for the oral targeted delivery of lipophilic drugs in type 2 diabetes (T2D). Probucol (PB) is an antihyperlipidemic and antioxidant drug with the potential to show benefits in T2D. We a...

Full description

Bibliographic Details
Main Authors: Mooranian, Armin, Negrulj, Rebecca, Chen-Tan, Nigel, Al-Sallami, H., Fang, Zhongxiang, Mukkur, Trilochan, Mikov, M., Golocorbin-Kon, S., Fakhoury, M., Watts, G., Matthews, V., Arfuso, Frank, Al-Salami, Hani
Format: Journal Article
Published: Dove Medical Press Ltd. 2014
Subjects:
artificial cell microencapsulation
Probucol
anti-inflammatory
diabetes
antioxidant
Online Access:http://hdl.handle.net/20.500.11937/7195

Internet

http://hdl.handle.net/20.500.11937/7195

Similar Items